search
Back to results

Acceptance and Commitment Therapy on Fatigue Interference in Patients With Advanced Lung Cancer and Caregiver Burden (ACT)

Primary Purpose

Lung Cancer, Advanced Cancer, Caregiver Burden

Status
Not yet recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Acceptance and Commitment Therapy (ACT) plus health education
Health education
Sponsored by
Chinese University of Hong Kong
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Lung Cancer focused on measuring lung cancer, palliative care, Acceptance and Commitment Therapy, cancer-related fatigue, caregiver burden

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: aged 18 or over; diagnosed with stage III or stage IV lung cancer by pathological section or cytology; lived in rural areas; experienced unexplained fatigue syndrome: the score of 3 or more on the Fatigue Symptom Inventory (FSI); able to provide informed consent and effectively collect data; a consenting primary family caregiver; and working phone service Exclusion Criteria: diagnosed with cognitive dysfunction or other mental illnesses that may interfere with their completion of treatment; who are at critical condition; and who are receiving or have just completed other lung cancer-related intervention programs within the last six months

Sites / Locations

  • Xiangya Hospital Central South University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

ACT group

Health eduction control group

Arm Description

Participants in the intervention group will receive ACT intervention, consisting of six online sessions via video conferencing platform (The first two sessions for patient only, the third and fourth sessions for caregiver only, and the last two sessions for patient-caregiver dyads) of 60-90 min each (once/week), in addition to health education.

Participants randomised to the health education control group will receive six weekly health education by a video-conferencing platform. The topics mainly include treatments and daily care during admission, medication instructions and side effects, diet and exercise advice, and retest recommendations when discharged.

Outcomes

Primary Outcome Measures

Eligibility rate
The eligiblity rate is defined as the percentage of participants fulfilling the inclusion criteria amongst the participants screened for the eligibility
Recruimtment rate
The recruitment rate is defined as the percentage of participants who consented to participate in the study amongst the participants eligible for the study
Attrition rate
The attrition rate is defined as the percentage of participants who withdrew from the study before completion
Adherence rate
The adherence rate is defined as the frequency of the practice of mindfulness and session attendance
Change from baseline in the score of fatigue interference assessed by The Fatigue Symptom Inventory at one week after the intervention
A 13-item instrument that measures the intensity and interference of fatigue over the previous 7 days. The first four items are used to assess the intensity of fatigue, Item 5 - Item 11 are to assess the degree to which fatigue in the past week was judged to interfere with different aspects, such as general activity, bathe and dress ability, work activity, concentration ability, relation with others, enjoyment of life and mood, using a 11-point Likert scale ranging from 0 (no interference) to 10 (extreme interference). 0 indicates no fatigue and 127 indicates the worst fatigue intensity and interference.
Change from baseline in the score of caregiver burden assessed by The Zarit Caregiver Burden Inventory at one week after the intervention
12 items score from 1(not always) to 5 (always) to assess caregiver burdens of caregivers of advanced lung cancer patients, including three domains: role strain, self-criticism, and negative emotion. The overall score can be obtained by adding all subscale scores. 12 indicates low caregiver burden and 60 indicates the highest caregiver burden.

Secondary Outcome Measures

Change from baseline in the score of health-related quality of life assessed by Functional Assessment of Cancer Therapy - Lung, Version 4 at one week after the intervention
36 items scored from 0 (not at all) to 4 (very much) to assess QoL of lung cancer patients, including 5 domains: physical, social/family, emotional, and functional well-being, and additional concerns about lung cancer. The overall score can be obtained by adding all subscale scores. 0 indicates no quality of life and 144 indicates the highest quality of life. Change= (One week after the intervention score - Baseline score)
Change from baseline in the score of meanfing of life assessed by The Meaning of Life questionnaire (MLQ) at one week after the intervention
8 items score from 0 (not at all) to 7 (totall agree) to assess meaning of life of caregivers of advanced lung cancer patients, including 2 domains: the Presence of Meaning subscale and the Search for Meaning subscale. The overall score can be obtained by adding all subscale scores. 0 indicates no meaning of life and 56 indicates the highest meaning of life.
Change from baseline in the score of psychological flexibility assessed by Comprehensive assessment of Acceptance and Commitment Therapy processes at three months after the intervention
A comprehensive ACT process measure to evaluate the level of psychological flexibility (and constituent sub-process) within the ACT model with 18 items ranged from 18 to 90. 18 indicates low level of psychological flexibility and 90 indicates the high level of psychological flexibility.
Change from baseline in the score of mindful attention assessed by Mindful Attention Awareness Scale at one week after the intervention
The trait MAAS is a 15-item scale designed to assess a core characteristic of mindfulness, scored from 1 (almost never) to 6 (almost always). 15 indicates low level of awareness and attention to present moment and 90 indicates the high level of awareness and attention to the present moment.

Full Information

First Posted
May 23, 2023
Last Updated
May 23, 2023
Sponsor
Chinese University of Hong Kong
Collaborators
Association for contextual behavioral science
search

1. Study Identification

Unique Protocol Identification Number
NCT05885984
Brief Title
Acceptance and Commitment Therapy on Fatigue Interference in Patients With Advanced Lung Cancer and Caregiver Burden (ACT)
Official Title
Effects of Acceptance and Commitment Therapy on Fatigue Interference in Patients With Advanced Lung Cancer and Caregiver Burden: A Pilot Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 2023 (Anticipated)
Primary Completion Date
November 2023 (Anticipated)
Study Completion Date
January 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chinese University of Hong Kong
Collaborators
Association for contextual behavioral science

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Lung cancer is a malignant tumour that has transformed from a single cancer disease into one of the most striking global health problems. Lung cancer has an insidious onset, and most patients are first diagnosed with the middle and advanced stages. Cancer-related fatigue is the most common and distressing symptom reported by lung cancer patients. For cancer patients, fatigue has a lasting impact on physical, psychological and social functions, and interferes with activities and participating in life events, thereby worsening the health-related quality of life. Family members have a key role in providing advanced lung cancer patients with informational, instrumental, and emotional support, which is crucial to patients' adaptation to the advanced illness and living a meaningful cancer life. Acceptance and Commitment Therapy (ACT) is the third-wave cognitive behavioural therapy to improve functioning and health-related quality of life by increasing psychological flexibility. The study aims to examine test the feasibility and acceptability, and preliminary effects of online ACT on fatigue interference in patients with advanced lung cancer and caregiver burden.
Detailed Description
A two-arm, assessor-blind randomised controlled trial will be conducted to investigate the effects of ACT on advanced lung cancer patients and caregivers compared to educational control. Participants in the same ward will be randomised at a 1:1 ratio to the intervention group or control group. Block randomization will be conducted by an independent research assistant using randomly varying block sizes of 4 and 6 to avoid selection bias. The study aims to examine the feasibility and acceptability, and preliminary effects of online ACT on fatigue interference in patients with advanced lung cancer and caregiver burden. The Specific objectives are: To investigate the feasibility and acceptability of the online 6-week ACT in patients with advanced lung cancer and caregivers in rural areas in China; To investigate the preliminary effects of the online 6-week ACT in patients with advanced lung cancer and caregivers in rural areas in China; To explore how patients and caregivers perceive the ACT experience during the intervention process.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Cancer, Advanced Cancer, Caregiver Burden
Keywords
lung cancer, palliative care, Acceptance and Commitment Therapy, cancer-related fatigue, caregiver burden

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants are assigned to two groups in parallel for the duration of the study. Participants in Group A receive Acceptance and Commitment Therapy in addition to health education. Participants in Group B receive health education.
Masking
Outcomes Assessor
Masking Description
The outcomes assessor who is independent of the research will be trained before formally conducting data collecting.
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
ACT group
Arm Type
Experimental
Arm Description
Participants in the intervention group will receive ACT intervention, consisting of six online sessions via video conferencing platform (The first two sessions for patient only, the third and fourth sessions for caregiver only, and the last two sessions for patient-caregiver dyads) of 60-90 min each (once/week), in addition to health education.
Arm Title
Health eduction control group
Arm Type
Other
Arm Description
Participants randomised to the health education control group will receive six weekly health education by a video-conferencing platform. The topics mainly include treatments and daily care during admission, medication instructions and side effects, diet and exercise advice, and retest recommendations when discharged.
Intervention Type
Behavioral
Intervention Name(s)
Acceptance and Commitment Therapy (ACT) plus health education
Intervention Description
Session 1: Reviewing experiences on struggles with CRF, realising consequence of controlling, introducing acceptance as an alternative, adopting virtual mindfulness. Education (patient): epidemiologic features of advanced lung cancer. Session 2: Separate thoughts/feelings related to CRF. Education (patient): treatments and symptoms of advanced lung cancer. Session 3: Reviewing caregiver's experiences of struggling with caregiving burden,introducing acceptance as an alternative. Education (caregiver): epidemiologic features of advanced lung cancer. Session 4: Separate caregivers' thoughts/feelings related to caregiving burden. Education (caregiver): treatments and symptoms of advanced lung cancer. Session 5:Understand the importance of values and clarifying personal values for dyads. Education (dyads): eating suggestions. Session 6: Emphasise ongoing value-based goals and commitment to actions for a meaningful cancer life for dyads. Education (dyads): exercising suggestions.
Intervention Type
Other
Intervention Name(s)
Health education
Intervention Description
Session 1: health education on the epidemiologic features of advanced lung cancer will be taught to patients. Session 2: health education on treatments and related symptoms of advanced lung cancer will be taught to patients. Session 3: health education on the epidemiologic features of advanced lung cancer will be taught to caregivers. Session 4: health education on treatments and related symptoms of advanced lung cancer will be taught to caregivers. Session 5: health education on eating suggestions for advanced lung cancer patients and caregivers will be taught. Session 6: health education on exercising suggestions for advanced lung cancer patients and caregivers will be taught.
Primary Outcome Measure Information:
Title
Eligibility rate
Description
The eligiblity rate is defined as the percentage of participants fulfilling the inclusion criteria amongst the participants screened for the eligibility
Time Frame
Before baseline
Title
Recruimtment rate
Description
The recruitment rate is defined as the percentage of participants who consented to participate in the study amongst the participants eligible for the study
Time Frame
Before baseline
Title
Attrition rate
Description
The attrition rate is defined as the percentage of participants who withdrew from the study before completion
Time Frame
After the 6-week intervention
Title
Adherence rate
Description
The adherence rate is defined as the frequency of the practice of mindfulness and session attendance
Time Frame
After the 6-week intervention
Title
Change from baseline in the score of fatigue interference assessed by The Fatigue Symptom Inventory at one week after the intervention
Description
A 13-item instrument that measures the intensity and interference of fatigue over the previous 7 days. The first four items are used to assess the intensity of fatigue, Item 5 - Item 11 are to assess the degree to which fatigue in the past week was judged to interfere with different aspects, such as general activity, bathe and dress ability, work activity, concentration ability, relation with others, enjoyment of life and mood, using a 11-point Likert scale ranging from 0 (no interference) to 10 (extreme interference). 0 indicates no fatigue and 127 indicates the worst fatigue intensity and interference.
Time Frame
Baseline (T0) and post-intervention (T1, one week after the 6-week intervention)
Title
Change from baseline in the score of caregiver burden assessed by The Zarit Caregiver Burden Inventory at one week after the intervention
Description
12 items score from 1(not always) to 5 (always) to assess caregiver burdens of caregivers of advanced lung cancer patients, including three domains: role strain, self-criticism, and negative emotion. The overall score can be obtained by adding all subscale scores. 12 indicates low caregiver burden and 60 indicates the highest caregiver burden.
Time Frame
Baseline (T0) and post-intervention (T1, one week after the 6-week intervention)
Secondary Outcome Measure Information:
Title
Change from baseline in the score of health-related quality of life assessed by Functional Assessment of Cancer Therapy - Lung, Version 4 at one week after the intervention
Description
36 items scored from 0 (not at all) to 4 (very much) to assess QoL of lung cancer patients, including 5 domains: physical, social/family, emotional, and functional well-being, and additional concerns about lung cancer. The overall score can be obtained by adding all subscale scores. 0 indicates no quality of life and 144 indicates the highest quality of life. Change= (One week after the intervention score - Baseline score)
Time Frame
Baseline (T0) and post-intervention (T1, one week after the 6-week intervention)
Title
Change from baseline in the score of meanfing of life assessed by The Meaning of Life questionnaire (MLQ) at one week after the intervention
Description
8 items score from 0 (not at all) to 7 (totall agree) to assess meaning of life of caregivers of advanced lung cancer patients, including 2 domains: the Presence of Meaning subscale and the Search for Meaning subscale. The overall score can be obtained by adding all subscale scores. 0 indicates no meaning of life and 56 indicates the highest meaning of life.
Time Frame
Baseline (T0) and post-intervention (T1, one week after the 6-week intervention)
Title
Change from baseline in the score of psychological flexibility assessed by Comprehensive assessment of Acceptance and Commitment Therapy processes at three months after the intervention
Description
A comprehensive ACT process measure to evaluate the level of psychological flexibility (and constituent sub-process) within the ACT model with 18 items ranged from 18 to 90. 18 indicates low level of psychological flexibility and 90 indicates the high level of psychological flexibility.
Time Frame
Baseline (T0) and post-intervention (T1, one week after the 6-week intervention)
Title
Change from baseline in the score of mindful attention assessed by Mindful Attention Awareness Scale at one week after the intervention
Description
The trait MAAS is a 15-item scale designed to assess a core characteristic of mindfulness, scored from 1 (almost never) to 6 (almost always). 15 indicates low level of awareness and attention to present moment and 90 indicates the high level of awareness and attention to the present moment.
Time Frame
Baseline (T0) and post-intervention (T1, one week after the 6-week intervention)
Other Pre-specified Outcome Measures:
Title
Acceptability of the intervention
Description
A convenience sample of 10 dyads in the intervention group will be recruited for focus group interviews to explore their ACT experience and overall satisfaction. The interview guide was developed based on the previous studies.
Time Frame
After the 6-week intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: aged 18 or over; diagnosed with stage III or stage IV lung cancer by pathological section or cytology; lived in rural areas; experienced unexplained fatigue syndrome: the score of 3 or more on the Fatigue Symptom Inventory (FSI); able to provide informed consent and effectively collect data; a consenting primary family caregiver; and working phone service Exclusion Criteria: diagnosed with cognitive dysfunction or other mental illnesses that may interfere with their completion of treatment; who are at critical condition; and who are receiving or have just completed other lung cancer-related intervention programs within the last six months
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Huiyuan LI, PhD
Phone
52665977
Email
huiyuanli@cuhk.edu.hk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Cho Lee WONG, PhD
Organizational Affiliation
The Nethersole School of Nursing, Chinese University of Hong Kong
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Huiyuan LI, PhD
Organizational Affiliation
The Nethersole School of Nursing, Chinese University of Hong Kong
Official's Role
Principal Investigator
Facility Information:
Facility Name
Xiangya Hospital Central South University
City
Changsha
State/Province
Hunan
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nina WANG, Master
Phone
+86 13974897928
Email
w.nn@qq.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Acceptance and Commitment Therapy on Fatigue Interference in Patients With Advanced Lung Cancer and Caregiver Burden (ACT)

We'll reach out to this number within 24 hrs